November 29, 2022
Article
Priorix and M-M-R II are fully interchangeable vaccines to protect against measles, mumps, and rubella, the CDC’s Advisory Committee on Immunization Practices said.
November 21, 2022
Earlier and higher rates of RSV and other respiratory illnesses following reduced COVID precautions challenge capacity of pediatric units.
November 14, 2022
Video
An ICU hospitalist talks about his criteria and the treatment protocols for these cases.
November 11, 2022
Dynavax reported results from its phase 1 study looking at its (Tdap-1018 CpG Adjuvanted) Tetanus/Diphtheria/Pertussis booster vaccine.
November 07, 2022
The benefits to children of wearing face masks to prevent COVID-19 outweigh potential infectious risks from face touching, according to a study analyzing hand-to-face contact in a simulated school environment.
The intranasal, live-attenuated vaccine CodaVax-RSV was granted FDA Fast Track designation. Clinical trials are expected to launch soon.
November 01, 2022
Vaccine efficacy of 81.8% was observed against severe medically attended lower respiratory tract illness due to respiratory syncytial virus (RSV) in infants from birth through the first 90 days of life.
October 24, 2022
Our cover story for the October 2022 print edition of Contagion details the original coronavirus.
October 22, 2022
The investigational vaccine was effective in reducing both lower respiratory tract and all respiratory tract infections.
October 21, 2022
Despite no significant reduction in time to discharge or recovery, inhalable SNG001 may lessen common symptoms of “long COVID.”
Pfizer-BioNTech Asks FDA to Authorize Omicron Bivalent COVID-19 Booster for Children Under 5 Years
Enterococcus Coinfection Enhances C Difficile Infection Severity
FDA Expands Use of Vemlidy to Adolescents with Chronic HBV Infection
Infectious Disease Update: This Week's Top 5 Stories
